tiprankstipranks
Trending News
More News >
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
Advertisement

Taysha Gene Therapies (TSHA) Revenue

Compare
1,072 Followers

Taysha Gene Therapies Revenue

Taysha Gene Therapies had a revenue of 1.99M in the quarter ending Jun 30, 2025, with -13.73%. This bring the company's revenue in the last twelve months to 8.10M, Decreased 12.10%. In the fiscal year ending Dec 31, 2024, Taysha Gene Therapies had annual revenue of 8.33M with -46.07% growth.
Revenue (ttm)
8.10M
Revenue Growth
-37.09%
P/S Ratio
91.33
Revenue/Employee
$114,151
Employees
73
Market Cap
$761.05M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
8.33M-7.12M-46.07%
Dec 31, 2023
15.45M12.95M+517.55%
Dec 31, 2022
2.50M+∞%
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis